Researchers study biofeedback for asthma

National Jewish Health researchers are delving into the biology of biofeedback to understand how it helps asthma patients and what role it could play in reducing medication use for the chronic lung disease. In a study funded by the National Institutes of Health, they are evaluating two forms of biofeedback, based on controlling heart rate and specific brain waves, and assessing their impact on inflammation in the lungs and the ‘twitchiness” of asthma patients’ airways.

“Previous studies have shown that can improve ’ lung function and reduce the need for medications,” said principal investigator Fred Wamboldt, MD, Professor of Medicine at National Jewish Health. “As such, biofeedback holds great promise for becoming an effective alternative to controller steroid medications. We need, however, to understand exactly how these techniques affects the lungs and airways before either can become an accepted therapy.”

Any therapy that could serve as an alternative or complement to steroid therapy would be especially welcome. Although inhaled steroids have been shown to be safe, many people are concerned about side effects, such as weight gain and reduced growth, and do not take adequate amounts to control their asthma. Any therapy that could improve asthma control while reducing the need for expensive medications would also be welcome.

Sensitive monitors can detect brain waves and minute variations in the . Researchers at National Jewish Health and the Robert Wood Johnson Medical School in New Jersey will attach those monitors to asthma patients, who will be able to see their and heart rate in real time. The researchers will then help the study participants learn  how to control these important body functions. Previous studies have shown that such techniques can improve lung function and reduce the need for asthma medications.

In this study, researchers will examine more closely the physiological effects of these types of biofeedback. Asthma has two primary components, and ‘twitchy’ muscles surrounding the airways, which can overreact to mild irritants, contract and close the airways. The researchers will measure airway ‘twitchiness’ with a test known as a methacholine challenge. They will monitor inflammation by measuring exhaled nitric oxide.

“These tests will help us better understand how biofeedback affects the lungs,” said Dr. Wamboldt. “That will help us understand whether they could be most effective as alternative or complementary therapies to controller steroid medications or to inhaled rescue medications.”

Provided by National Jewish Health

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Can text messaging improve medication adherence?

May 24, 2011

Text messaging and adolescents don’t always mix well, but researchers at National Jewish Health hope text messages can spur teenagers to take their asthma medications more reliably. The study is testing whether health ...

Steroids not as effective in obese asthma patients

Sep 16, 2008

Researchers at National Jewish Health have shown that glucocorticoids, the primary controller medication for asthma, are 40 percent less effective in overweight and obese asthma patients than in those of normal weight. The ...

Recommended for you

Ivory Coast closes borders with Ebola-hit neighbours

3 hours ago

The Ivory Coast has closed its borders with Ebola-hit Guinea and Liberia in a bid to protect citizens against an epidemic that has killed 1,427 people across West Africa, the prime minister said Saturday.

How the world is underestimating Ebola: WHO

11 hours ago

The Ebola epidemic tearing through western Africa is by far the deadliest known outbreak of the disease, yet the magnitude of the spread is believed to be severely underestimated.

Last Ebola-free region of Liberia falls to virus

12 hours ago

Every region of Liberia has now been hit by Ebola, officials said Friday, as the World Health Organization warned the fight against the worst-ever outbreak of the killer disease would take months.

Ebola death toll rises to 1,427: WHO

22 hours ago

The death toll from the Ebola outbreak sweeping through west African countries has risen to 1,427 out of more than 2,600 cases, the World Health Organization said Friday.

User comments